FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to orthopaedics, and can be used for correcting the bone tissue status and preventing fractures in cardiovascular patients. That is ensured by administering Calcemin advance 1 tablet 1-3 times a day with meals for 6 months.
EFFECT: method enables preventing fractures by increasing bone mineral density (BMD) with reducing neurological symptoms that reduces a risk of patients' fall-downs.
1 tbl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ASSESSING MINERAL DENSITY OF BONE TISSUE IN PATIENTS WITH CHRONIC HEART FAILURE | 2013 |
|
RU2565833C2 |
| METHOD OF TREATING POSTMENOPAUSAL OSTEPOROSIS | 2009 |
|
RU2424815C2 |
| METHOD FOR SUPPORTING TREATMENT IN LARGE JOINT REPLACEMENT | 2012 |
|
RU2527159C2 |
| METHOD OF TREATING PROXIMAL HUMERAL INJURIES | 2013 |
|
RU2547610C1 |
| METHOD OF POSTMENOPAUSAL OSTEOPOROSIS THERAPY | 2009 |
|
RU2423982C2 |
| METHOD FOR PREVENTING OSTEOPOROSIS IN PATIENTS WITH CICD | 2005 |
|
RU2294747C1 |
| AGENT FOR LOW-TURNOVER METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2491940C1 |
| AGENT FOR LOW-METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2485957C1 |
| METHOD FOR PREDICTING THE PRESENCE OF OSTEOPOROSIS BY THE LEVEL OF ARTERIAL STIFFNESS AMONG PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR COMPLICATIONS | 2020 |
|
RU2746837C1 |
| METHOD FOR PREDICTING THE PRESENCE OF CALCINOSIS OF CORONARY ARTERIES AND THORACIC AORTA BY THE LEVEL OF ARTERIAL STIFFNESS IN THE PATIENTS OF HIGH RISK OF CARDIOVASCULAR COMPLICATIONS WITH REDUCED MINERAL DENSITY OF BONE TISSUE | 2019 |
|
RU2723361C1 |
